{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:17:50Z","timestamp":1790785070993,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence of drugs in surface and groundwaters adversely affects the physiological function of non-target organisms due special activities that can pose a serious threats to various forms of aquatic life. Psychotropic drugs are one of the most commonly used drugs in the world. Hence, the aim of this study was to investigate the effect of environmentally-relevant concentrations of the antipsychotic drugs, sulpiride and clozapine, on dopaminergic (DAergic) and serotonergic (5-HTergic) neurotransmitter systems in the brain of zebrafish. Adult zebrafish (AB strain) were exposed to the environmentally-relevant concentrations of sulpiride, clozapine, or a mixture of sulpiride and clozapine. The effects of the drugs on the mRNA and protein levels of major functional molecules in DAergic and 5-HTergic systems were then analyzed in the telencephalon and diencephalon. Both drugs induced abnormal mRNA and protein levels of important functional molecules of the DA and 5-HT signaling pathways in both telencephalon and diencephalon, as shown by the abnormal transcriptional levels of <jats:italic>TH<\/jats:italic>, <jats:italic>DAT<\/jats:italic>, <jats:italic>DR D1<\/jats:italic>, <jats:italic>DR D2<\/jats:italic>, <jats:italic>MAO<\/jats:italic>, <jats:italic>TPH<\/jats:italic>, <jats:italic>serotonin transporter (SERT)<\/jats:italic>, <jats:italic>5-HTR 1AA<\/jats:italic>, <jats:italic>5-HTR 1B<\/jats:italic>, <jats:italic>5-THR 2AA<\/jats:italic>, and <jats:italic>5-HTR 2B<\/jats:italic>, and the abnormal translational levels of DAT, DR D2, SERT, 5-HTR 1A, 5-HTR 1B, and 5-HTR 2B. In addition, we observed a specificity in the adverse effects of these antipsychotic drugs, in terms of doses and brain parts. Compared to their effects alone, the drug mixture had a weaker effect on the DA and 5-HT systems, suggesting an antagonistic interaction between sulpiride and clozapine. Our findings suggest that sulpiride and clozapine interfere with DAergic and 5-HTergic neurotransmitter systems in the telencephalon and diencephalon of zebrafish, resulting in possible effects on brain functions and posing a serious threat to the health of zebrafish.<\/jats:p>","DOI":"10.1038\/s41598-022-22169-1","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:09:20Z","timestamp":1666789760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Environmentally-relevant concentrations of the antipsychotic drugs sulpiride and clozapine induce abnormal dopamine and serotonin signaling in zebrafish brain"],"prefix":"10.1038","volume":"12","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"issue":"5","key":"22169_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.chemosphere.2011.12.025","volume":"87","author":"E Gracia-Lor","year":"2012","unstructured":"Gracia-Lor, E., Sancho, J. V., Serrano, R. & Hernandez, F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 87(5), 453\u2013462 (2012).","journal-title":"Chemosphere"},{"key":"22169_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.scitotenv.2014.05.087","volume":"490","author":"ZH Wen","year":"2014","unstructured":"Wen, Z. H. et al. Occurrence and human health risk of wastewater-derived pharmaceuticals in a drinking water source for Shanghai, East China. Sci. Total Environ. 490, 987\u2013993 (2014).","journal-title":"Sci. Total Environ."},{"issue":"1\u20133","key":"22169_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhazmat.2009.10.100","volume":"175","author":"LH Santos","year":"2010","unstructured":"Santos, L. H. et al. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 175(1\u20133), 45\u201395 (2010).","journal-title":"J. Hazard. Mater."},{"issue":"3","key":"22169_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/etc.3244","volume":"35","author":"GC Nallani","year":"2016","unstructured":"Nallani, G. C. et al. Bioconcentration of two basic pharmaceuticals, verapamil and clozapine, in fish. Environ. Toxicol. Chem. 35(3), 593\u2013603 (2016).","journal-title":"Environ. Toxicol. Chem."},{"issue":"3","key":"22169_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","volume":"23","author":"T Ott","year":"2019","unstructured":"Ott, T. & Nieder, A. Dopamine and cognitive control in prefrontal cortex. Trends Cogn. Sci. 23(3), 213\u2013234 (2019).","journal-title":"Trends Cogn. Sci."},{"issue":"5","key":"22169_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.tins.2021.01.002","volume":"44","author":"R Lin","year":"2021","unstructured":"Lin, R., Liang, J. & Luo, M. The raphe dopamine system: Roles in salience encoding, memory expression, and addiction. Trends Neurosci. 44(5), 366\u2013377 (2021).","journal-title":"Trends Neurosci."},{"issue":"1","key":"22169_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2010.05.010","volume":"40","author":"P Panula","year":"2010","unstructured":"Panula, P. et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol. Dis. 40(1), 46\u201357 (2010).","journal-title":"Neurobiol. Dis."},{"issue":"18","key":"22169_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1002\/cne.22735","volume":"519","author":"LA O'Connell","year":"2011","unstructured":"O\u2019Connell, L. A. & Hofmann, H. A. The vertebrate mesolimbic reward system and social behavior network: A comparative synthesis. J. Comp. Neurol. 519(18), 3599\u20133639 (2011).","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"22169_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1515\/rns.2011.012","volume":"22","author":"BR Souza","year":"2011","unstructured":"Souza, B. R. & Tropepe, V. The role of dopaminergic signalling during larval zebrafish brain development: A tool for investigating the developmental basis of neuropsychiatric disorders. Rev. Neurosci. 22(1), 107\u2013119 (2011).","journal-title":"Rev. Neurosci."},{"issue":"Pt A","key":"22169_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.expneurol.2017.10.004","volume":"299","author":"BD Fontana","year":"2018","unstructured":"Fontana, B. D., Mezzomo, N. J., Kalueff, A. V. & Rosemberg, D. B. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review. Exp. Neurol. 299(Pt A), 157\u2013171 (2018).","journal-title":"Exp. Neurol."},{"key":"22169_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbr.2016.01.034","volume":"303","author":"M Naderi","year":"2016","unstructured":"Naderi, M., Jamwal, A., Chivers, D. P. & Niyogi, S. Modulatory effects of dopamine receptors on associative learning performance in zebrafish (Danio rerio). Behav. Brain Res. 303, 109\u2013119 (2016).","journal-title":"Behav. Brain Res."},{"key":"22169_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pnpbp.2016.01.002","volume":"67","author":"M Naderi","year":"2016","unstructured":"Naderi, M., Jamwal, A., Ferrari, M. C., Niyogi, S. & Chivers, D. P. Dopamine receptors participate in acquisition and consolidation of latent learning of spatial information in zebrafish (Danio rerio). Prog. Neuropsychopharmacol. Biol. Psychiatry 67, 21\u201330 (2016).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"22169_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pnpbp.2014.03.008","volume":"55","author":"AM Herculano","year":"2014","unstructured":"Herculano, A. M. & Maximino, C. Serotonergic modulation of zebrafish behavior: Towards a paradox. Prog. Neuropsychopharmacol. Biol. Psychiatry 55, 50\u201366 (2014).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"22169_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/jnc.14978","volume":"153","author":"M Lima-Maximino","year":"2020","unstructured":"Lima-Maximino, M. et al. Phasic and tonic serotonin modulate alarm reactions and post-exposure behavior in zebrafish. J. Neurochem. 153(4), 495\u2013509 (2020).","journal-title":"J. Neurochem."},{"issue":"3","key":"22169_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/toxics4030019","volume":"4","author":"KA Horzmann","year":"2016","unstructured":"Horzmann, K. A. & Freeman, J. L. Zebrafish get connected: Investigating neurotransmission targets and alterations in chemical toxicity. Toxics 4(3), 19 (2016).","journal-title":"Toxics"},{"key":"22169_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pbb.2014.09.022","volume":"126","author":"M Nowicki","year":"2014","unstructured":"Nowicki, M., Tran, S., Muraleetharan, A., Markovic, S. & Gerlai, R. Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner. Pharmacol. Biochem. Behav. 126, 170\u2013180 (2014).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"22169_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neubiorev.2021.06.022","volume":"128","author":"E Courtiol","year":"2021","unstructured":"Courtiol, E., Menezes, E. C. & Teixeira, C. M. Serotonergic regulation of the dopaminergic system: Implications for reward-related functions. Neurosci. Biobehav. Rev. 128, 282\u2013293 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"22169_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jhazmat.2016.08.022","volume":"320","author":"AF Bollmann","year":"2016","unstructured":"Bollmann, A. F. et al. Occurrence and fate of amisulpride, sulpiride, and lamotrigine in municipal wastewater treatment plants with biological treatment and ozonation. J. Hazard. Mater. 320, 204\u2013215 (2016).","journal-title":"J. Hazard. Mater."},{"key":"22169_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.envpol.2015.04.021","volume":"204","author":"Z Wang","year":"2015","unstructured":"Wang, Z., Zhang, X. H., Huang, Y. & Wang, H. Comprehensive evaluation of pharmaceuticals and personal care products (PPCPs) in typical highly urbanized regions across China. Environ. Pollut. 204, 223\u2013232 (2015).","journal-title":"Environ. Pollut."},{"issue":"4","key":"22169_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4), 402\u2013408 (2001).","journal-title":"Methods"},{"key":"22169_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.scitotenv.2019.07.042","volume":"690","author":"KS Guruge","year":"2019","unstructured":"Guruge, K. S. et al. First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways. Sci. Total Environ. 690, 683\u2013695 (2019).","journal-title":"Sci. Total Environ."},{"issue":"10","key":"22169_CR22","doi-asserted-by":"publisher","first-page":"6663","DOI":"10.1007\/s10661-014-3881-8","volume":"186","author":"KP Singh","year":"2014","unstructured":"Singh, K. P., Rai, P., Singh, A. K., Verma, P. & Gupta, S. Occurrence of pharmaceuticals in urban wastewater of north Indian cities and risk assessment. Environ. Monit. Assess. 186(10), 6663\u20136682 (2014).","journal-title":"Environ. Monit. Assess."},{"key":"22169_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.marpolbul.2018.08.036","volume":"135","author":"P Reis-Santos","year":"2018","unstructured":"Reis-Santos, P. et al. Screening of human and veterinary pharmaceuticals in estuarine waters: A baseline assessment for the Tejo estuary. Mar. Pollut. Bull. 135, 1079\u20131084 (2018).","journal-title":"Mar. Pollut. Bull."},{"key":"22169_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jchromb.2016.10.031","volume":"1038","author":"F Logarinho","year":"2016","unstructured":"Logarinho, F. et al. Determination of antipsychotic drugs in hospital and wastewater treatment plant samples by gas chromatography\/tandem mass spectrometry. J. Chromatogr. B 1038, 127\u2013135 (2016).","journal-title":"J. Chromatogr. B"},{"issue":"10","key":"22169_CR25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.chemosphere.2012.10.089","volume":"90","author":"S Yuan","year":"2013","unstructured":"Yuan, S., Jiang, X., Xia, X., Zhang, H. & Zheng, S. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 90(10), 2520\u20132525 (2013).","journal-title":"Chemosphere"},{"issue":"1\u20132","key":"22169_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0006-8993(00)03174-7","volume":"889","author":"E Rink","year":"2001","unstructured":"Rink, E. & Wullimann, M. F. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res. 889(1\u20132), 316\u2013330 (2001).","journal-title":"Brain Res."},{"issue":"1","key":"22169_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/cne.10544","volume":"460","author":"PM Ma","year":"2003","unstructured":"Ma, P. M. Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon. J. Comp. Neurol. 460(1), 13\u201337 (2003).","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"22169_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cne.903440207","volume":"344","author":"PM Ma","year":"1994","unstructured":"Ma, P. M. Catecholaminergic systems in the zebrafish. II. Projection pathways and pattern of termination of the locus coeruleus. J. Comp. Neurol. 344(2), 256\u201369 (1994).","journal-title":"J. Comp. Neurol."},{"key":"22169_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","volume":"151","author":"P De Deurwaerdere","year":"2017","unstructured":"De Deurwaerdere, P. & Di Giovanni, G. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. Prog. Neurobiol. 151, 175\u2013236 (2017).","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"22169_CR30","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.neuron.2015.04.015","volume":"86","author":"M Pignatelli","year":"2015","unstructured":"Pignatelli, M. & Bonci, A. Role of dopamine neurons in reward and aversion: A synaptic plasticity perspective. Neuron 86(5), 1145\u20131157 (2015).","journal-title":"Neuron"},{"issue":"8","key":"22169_CR31","first-page":"900","volume":"16","author":"HY Meltzer","year":"2017","unstructured":"Meltzer, H. Y. New trends in the treatment of schizophrenia. CNS Neurol. Disord. Drug Targets 16(8), 900\u2013906 (2017).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"22169_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/npp.2010.151","volume":"36","author":"YL Boureau","year":"2011","unstructured":"Boureau, Y. L. & Dayan, P. Opponency revisited: Competition and cooperation between dopamine and serotonin. Neuropsychopharmacology 36(1), 74\u201397 (2011).","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"22169_CR33","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.bjp.0705328","volume":"139","author":"LJ Boothman","year":"2003","unstructured":"Boothman, L. J., Allers, K. A., Rasmussen, K. & Sharp, T. Evidence that central 5-HT2A and 5-HT2B\/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br. J. Pharmacol. 139(5), 998\u20131004 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"22169_CR34","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.neuropharm.2020.108155","volume":"177","author":"T Sharp","year":"2020","unstructured":"Sharp, T. & Barnes, N. M. Central 5-HT receptors and their function; present and future. Neuropharmacology 177, 108155 (2020).","journal-title":"Neuropharmacology"},{"key":"22169_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.147174","volume":"784","author":"S Aydin","year":"2021","unstructured":"Aydin, S., Beduk, F., Ulvi, A. & Aydin, M. E. Simple and effective removal of psychiatric pharmaceuticals from wastewater treatment plant effluents by magnetite red mud nanoparticles. Sci. Total Environ. 784, 147174 (2021).","journal-title":"Sci. Total Environ."},{"issue":"10","key":"22169_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.chemosphere.2009.09.021","volume":"77","author":"V Calisto","year":"2009","unstructured":"Calisto, V. & Esteves, V. I. Psychiatric pharmaceuticals in the environment. Chemosphere 77(10), 1257\u20131274 (2009).","journal-title":"Chemosphere"},{"issue":"3","key":"22169_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S2215-0366(20)30565-4","volume":"8","author":"YF Lo","year":"2021","unstructured":"Lo, Y. F., Yang, F. C., Huang, J. S., Lin, Y. S. & Liang, C. S. Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder. Lancet Psychiatry 8(3), 179 (2021).","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"22169_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet, M., Geddes, J. R., Husain, M., Luciano, S. & Harrison, P. J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry 8(5), 416\u2013427 (2021).","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"22169_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.5498\/wjp.v11.i10.821","volume":"11","author":"C Putri","year":"2021","unstructured":"Putri, C., Arisa, J., Hananto, J. E., Hariyanto, T. I. & Kurniawan, A. Psychiatric sequelae in COVID-19 survivors: A narrative review. World J. Psychiatry 11(10), 821\u2013829 (2021).","journal-title":"World J. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22169-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:30:09Z","timestamp":1666791009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22169-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"14 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17973"}}